Phase I study of CNTO 95, a fully human monoclonal antibody to αv integrins, docetaxel, and prednisone in hormone refractory prostate cancer patients (HRPCP)
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: F. M. Chu, J. Picus, M. Mata, C. Kopacynski, B. Foster, Z. Lang, R. A. Beckman, R. Dreicer
Institution: Cleveland Clinic
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2227390522